Fintech PR
UK Workplace Safety Risks Are Far Too High
![uk-workplace-safety-risks-are-far-too-high](https://thefintechbuzz.com/wp-content/uploads/2023/12/48536-uk-workplace-safety-risks-are-far-too-high.png)
New Global Benchmarking Research Shows Lack of EHS Maturity and Future-Readiness
SYDNEY and FRISCO, Texas, Dec. 18, 2023 /PRNewswire/ — As the working year draws to a close, new research shows 97% of workplaces in the United Kingdom are still too vulnerable to health and safety risks. Of those 8.7% are exposed to unacceptably high levels of risk.
Only 3% of organisations believe they are ready to manage their environmental health and safety (EHS) risks. This is despite increasing advocacy for zero risk in the workplace.
The research shows a central problem is the ability to capture vital data, and then action that data in time to prevent or respond to an incident or crisis. The research included more than 1,000 EHS professionals across 20 industries worldwide and was undertaken by independent analyst firm Focus Networks.
A staggering 68% of EHS leaders do not have confidence in the quality and quantity of data being captured. (See key findings below.) This is not to say EHS professionals are not keeping their workers safe, but that they believe processes could be made much better.
‘Behavioural economics tells us that executives are overconfident when assessing an organization’s ability to respond to future events. And we also know that one of the best antidotes for overconfidence is objective data. A 68% no-confidence vote by EHS professionals is very objective and very telling’, said Andrew Milroy, author of the report and lead researcher at Focus Networks, the firm HSI commissioned to undertake the survey.
‘As much as we’d like to think otherwise, risk management is in its adolescence. And ineffective or faulty evaluation of risk likelihood and severity can be extremely serious in EHS, just as it is in cybersecurity,’ said, Jose Arcilla, President & Chief Operations Officer, HSI, the company that commissioned the research.
‘From a risk perspective, we can’t keep thinking “if this happens”, but rather “when this happens”. And, if you’re not prepared to answer the “when” question, you either have a healthy appetite for risk or are extremely complacent. Neither are good,’ Arcilla added.
EHS maturity varies across industries. For example, healthcare and construction both have high risk levels, but their maturity is quite different. Healthcare has a maturity score of 63.6 out of 100 and is the best-performing industry. By contrast, the construction industry scored only 49.3 for maturity out of a possible 100, effectively a fail.
In response to the research being presented at the World Congress on Health and Safety in Sydney Australia, the Assistant Secretary of the Australian Council of Trade Unions (ACTU), Liam O’Brien said, ‘All working people should have the right to a safe workplace, but the HSI Donesafe research confirms the lack of health and safety capability is all too common in Australia. A key shortcoming is the failure by some businesses to consult and involve workers and their representatives in the design of their health and safety systems, despite workers being the ones who actually perform the work and understand its risks.
‘ACTU research last year supports these new findings, with 20-25 percent of workers saying that employers did not consult or involve them in decision-making about their own health and safety – that has to change.’
But there is good news.
‘There are a small number of big factors that make a difference,’ said Milroy.
‘First, many organisations are in a complexity blizzard. They can barely see the terrain they are on. This is because there are too many disconnected systems.
‘Safety data is typically time-sensitive and too many organisations cannot action data in time. Often people don’t even know where or how to report an issue. So, a simple, integrated system solves many problems,’ Milroy said.
The research also found that most organisations approached health and safety in terms of compliance, rather than as a part of risk management or as an investment in people and culture.
‘Compliance is a grudge purchase. So, it is no wonder people are not engaging with safety systems and don’t adopt better practices. The leadership team needs to change the narrative on health and safety, so it becomes part of the vision,’ Milroy said.
The research shows that best-practice organisations that have integrated technology and data dramatically reduce complexity. They also focus on the safety of the whole person, which goes beyond physical risks to include psychosocial factors such as anxiety and bullying, as well as cybersecurity and privacy.
‘Yes, technology has developed in leaps and bounds, especially in our ability to integrate and use data in real time, but ultimately this is a leadership matter. It is about risk management and corporate culture. It is about the organisation you want to be, not compliance, and if you don’t understand that you will fall further behind,’ said Jose Arcilla.
The Report was prepared by Focus Networks and commissioned by HSI.
A copy of the report can be found here.
Key Findings for Decision Makers
Compliance and engagement
75.8% of organizations are compliance-focused and struggle to engage their people
67.1% of organizations are simply ‘operational’ with limited digitisation
88.3% of organizations are vulnerable, in one way or another to risk, and falling behind in their EHS processes
70% of EHS leaders are saddled with multiple point solutions versus a multi-solution platform, increasing their lack of data integrity
68% of leaders report gaps in the security and privacy capabilities of their EHS process
Gaining executive support is the leading concern with implementing a new EHS platform
Reducing workplace incidents and injuries is the leading expected outcome of a new EHS platform, followed by the desire to reduce time spent on administrative tasks
An increasing number of respondents, 57%, are focused on consolidating vendors and costs
A major challenge for immature organizations is effectively engaging their staff and workforce on EHS issues.
Lack of connectivity
In terms of connectivity, 47% of participants cited disparate systems as a major capability gap.
The relationship between complexity and technology is misunderstood
State-of-the-art technology can dramatically simplify data collection, analysis and action, yet far too few organizations understand this relationship, instead preferring to keep adding stand-alone technology that is difficult to integrate.
Contemporary and emerging technologies will improve EHS readiness but, so far, only the most mature organizations understand this potential and have acted on it.
Largest capability gaps
The four biggest gaps overall are:
- Lack of engagement with staff and workforce
- Lack of integrated data that can be actioned in real time
- Low or non-existent resources allocated to psychosocial and mental health challenges
- Security and privacy issues
Risk Level and EHS Maturity by Industry
Industry |
Risk |
Maturity Level |
Maturity |
Oil and gas |
Very high |
Operational |
57.3 |
Mining and metals |
Very high |
Operational |
56.4 |
Healthcare |
High |
Progressive |
63.6 |
Utilities |
High |
Progressive |
61.1 |
Construction |
High |
Foundational |
49.3 |
Transport and logistics |
High |
Operational |
52.9 |
Agriculture |
High |
Operational |
51.1 |
Manufacturing |
Medium |
Operational |
56.6 |
Automotive |
Medium |
Operational |
56.7 |
Retail |
Medium |
Operational |
59.7 |
Government |
Low |
Progressive |
61.2 |
Education |
Low |
Operational |
58.2 |
Methodology
In the second half of 2023, Focus Network, in collaboration with HSI, conducted 1,013 interviews and surveys of EHS decision-makers across the globe, distributed across more than 20 industries. Respondents were asked a series of questions relating to each component of the EHS function. Responses to these questions were then used to determine maturity for each component. A number of categories were determined for overall mean maturity scores in terms of readiness and in terms of risk.
Global breakdown of responses: 37% North America, 29% ANZ, 26% UK, 7% Other Countries
Organisation size: 41% greater than 1,000 total employees, 59% lower than 1,000 total employees
About HSI Donesafe
HSI Donesafe, a global integrated EHSQ and ESG software leader, has redefined how modern workplaces realize safer, smarter and more sustainable ways of working. Donesafe is an advanced cloud-native platform for achieving universal regulatory compliance, risk management and data reporting.
Built with next-generation no-code technology, the Donesafe platform boasts 50+ adaptive modules. This unmatched configurability empowers clients to effortlessly co-design their own modules with drag-and-drop ease, unlocking a world of possibilities, all managed within a single source platform.
Used by over 3 million people globally, the Donesafe platform is trusted by the world’s largest organizations, including governments, for its next-level security , privacy, and authentication standards. It delivers a world-class suite of enterprise support services, integration connectivities, and business intelligence (BI) reporting capabilities, designed to keep future-ready workplaces adapting at pace.
For more information, visit: https://www.donesafe.com.
HSI Donesafe is a division of HSI, a global single-source partner for EHS, ESG, training, compliance and professional development solutions with over 40 years of experience supporting enterprises, including many Fortune 500 companies, spanning 22,000 customers across 71 countries.
For more information, visit: https://www.hsi.com.
View original content:https://www.prnewswire.co.uk/news-releases/uk-workplace-safety-risks-are-far-too-high-302017454.html
Fintech PR
Invitation to presentation of EQT AB’s Q1 Announcement 2024
![invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024](https://thefintechbuzz.com/wp-content/uploads/2024/04/51875-invitation-to-presentation-of-eqt-abs-q1-announcement-2024.png)
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
Fintech PR
Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs
![kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs](https://thefintechbuzz.com/wp-content/uploads/2024/04/51877-kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs.jpg)
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
Fintech PR
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
![biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update](https://thefintechbuzz.com/wp-content/uploads/2024/04/51873-biovaxys-technology-corp-provides-bi-weekly-mcto-status-update.jpg)
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News6 days ago
China remains stabilizing force for global economic growth
-
Latest News5 days ago
Kylian Mbappé and Accor Forge Alliance to Empower Younger Generations
-
Latest News3 days ago
Martello Re announces closing of $1.3 billion capital raise consisting of $935 million in equity and a $360 million upsize of the Company’s credit facility
-
Latest News4 days ago
BioCatch completes best first half in company history, grows ARR by 43% YoY
-
Latest News4 days ago
Market Dojo Celebrates Prestigious Inclusion in Ardent Partners 2024 Strategic Sourcing Technology Advisor
-
Latest News2 days ago
Driving Innovation Forward: CFI Welcomes Seven-Time Formula 1™ World Champion Lewis Hamilton as new Global Brand Ambassador
-
Latest News2 days ago
KEYSTONE BANK HOLDS CUSTOMER FORUM, REITERATES COMMITMENT TO EXCELLENT SERVICE DELIVERY
-
Latest News5 days ago
COP28 President calls on all stakeholders to bring spirit of solidarity that delivered UAE Consensus to drive implementation and sustainable socio-economic development